Advances in the use of biologic agents for the treatment of systemic vasculitis
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Rheumatology
Reference58 articles.
1. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases;Cantini;Arthritis Rheum,2001
2. Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis;Andonopoulos;Ann Rheum Dis,2003
3. Antitumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs;Airo;Rheumatology (Oxford),2002
4. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial;Hoffman;Ann Intern Med,2007
5. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects;Martinez-Taboada;Ann Rheum Dis,2008
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Increased Risk of Preterm Delivery Subtypes and Hypertensive Disorders of Pregnancy in First Deliveries of Patients With Systemic Vasculitis;ACR Open Rheumatology;2024-07-06
2. Informed consent and biological agents in rheumatology and internal medicine;European Journal of Clinical Investigation;2022-05-18
3. Treatment strategy ANCA-associated renal vasculitides in children and adolescents;Nephrology (Saint-Petersburg);2019-08-08
4. Infliximab for the treatment of refractory polyarteritis nodosa;Clinical Rheumatology;2019-04-10
5. Molecularly targeted agents in oculoplastic surgery;Current Opinion in Ophthalmology;2017-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3